Brief: Lantern Pharma Inc. - Announced Expansions And Updates To RADR's Product Roadmap
15/02/2023 14:02
Feb 15 (Reuters) - Lantern Pharma Inc. LTRN.O :
* LANTERN PHARMA INC. - ANNOUNCED EXPANSIONS AND UPDATES TO
RADR'S
PRODUCT ROADMAP
* LANTERN PHARMA - RADR ADVANCEMENTS WILL FOCUS ON
ADDITIONAL
INNOVATIVE AI AND ML APPROACHES TO DEVELOP ANTIBODY DRUG
CONJUGATES
Source text for Eikon: ID:nBw50pFwja
Further company coverage: LTRN.O
((Reuters.briefs@thomsonreuters.com;))
Recent news on Lantern Pharma
See all newsBrief: Lantern Pharma Reports HARMONIC Data Showing LP-300 Progression-Free Survival Benefit Deepens With Treatment Duration In EGFR Exon 21 L858R Lung Cancer
Brief: Lantern Pharma Announces Successful Outcome Of FDA Type C Meeting Request For Harmonic Phase 2 Trial of LP-300 In Never-Smokers With NSCLC
Lantern Pharma Q1 net loss narrows on R&D cost cuts
Brief: Lantern Pharma Inc. Announces Up To $9.25 Million Registered Direct Offering With Existing Holders And A Single Institutional Investor
Brief: Lantern Pharma Inc - Schedules Type C FDA Meeting For Harmonic Protocol Amendments